LEXARIA BIOSCIENCE CORP. Interest Expense
LEXARIA BIOSCIENCE CORP. (LEXX) reported Interest Expense of $0 for the 3-month period ending 2018-05-31, per its 10-Q filed 2018-07-13.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2018-11-14
- LEXARIA BIOSCIENCE CORP. interest expense for the quarter ending 2018-05-31 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. interest expense for the quarter ending 2018-02-28 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. interest expense for the quarter ending 2017-11-30 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. interest expense for the quarter ending 2017-08-31 was $1.13K, a 0.00% change year-over-year.
- LEXARIA BIOSCIENCE CORP. interest expense for fiscal 2017 was $6.01K, a 167.33% increase from fiscal 2016.
- LEXARIA BIOSCIENCE CORP. interest expense for fiscal 2016 was $2.25K, a 92.87% decline from fiscal 2015.
- LEXARIA BIOSCIENCE CORP. interest expense for fiscal 2015 was $31.54K, a 80.97% decline from fiscal 2014.
- LEXARIA BIOSCIENCE CORP. interest expense for fiscal 2014 was $165.79K.
| Period end | Interest Expense 2 month | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 10 month | Interest Expense 12 month |
|---|---|---|---|---|---|---|
| 2018-05-31 | $0.00 10-Q · filed 2018-07-13 | $0.00 derived: sum of 2 quarters · filed 2018-07-13 | $0.00 10-Q · filed 2018-07-13 | $1.13K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2018-02-28 | $0.00 10-Q · filed 2018-04-12 | $0.00 10-Q · filed 2018-04-12 | $1.13K derived: sum of 3 quarters · filed 2018-11-14 | $2.71K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-11-30 | $0.00 10-Q · filed 2018-01-12 | $1.13K derived: sum of 2 quarters · filed 2018-11-14 | $2.71K derived: sum of 3 quarters · filed 2018-11-14 | $4.66K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-08-31 | $1.13K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $2.71K derived: sum of 2 quarters · filed 2018-11-14 | $4.66K derived: sum of 3 quarters · filed 2018-11-14 | $6.01K 10-K · filed 2018-11-14 | ||
| 2017-05-31 | $1.58K 10-Q · filed 2018-07-13 | $3.54K derived: sum of 2 quarters · filed 2018-07-13 | $4.89K 10-Q · filed 2018-07-13 | $6.01K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-02-28 | $1.95K 10-Q · filed 2018-04-12 | $3.31K 10-Q · filed 2018-04-12 | $4.43K derived: sum of 3 quarters · filed 2018-11-14 | $5.48K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2016-11-30 | $1.35K 10-Q · filed 2018-01-12 | $2.48K derived: sum of 2 quarters · filed 2018-11-14 | $3.53K derived: sum of 3 quarters · filed 2018-11-14 | $3.53K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2016-08-31 | $1.13K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $2.17K derived: sum of 2 quarters · filed 2018-11-14 | $2.17K derived: sum of 3 quarters · filed 2018-11-14 | $2.25K 10-K · filed 2018-11-14 | ||
| 2016-05-31 | $1.05K 10-Q · filed 2017-07-14 | $1.05K derived: sum of 2 quarters · filed 2017-07-14 | $1.13K 10-Q · filed 2017-07-14 | $1.12K derived: sum of 4 quarters · filed 2017-07-14 | ||
| 2016-02-29 | $0.00 10-Q · filed 2017-04-14 | $78.00 10-Q · filed 2017-04-14 | $77.00 derived: sum of 3 quarters · filed 2017-04-14 | $77.00 derived: sum of 4 quarters · filed 2017-04-14 | ||
| 2015-11-30 | $77.00 10-Q · filed 2017-01-13 | $77.00 derived: sum of 2 quarters · filed 2017-01-13 | $77.00 derived: sum of 3 quarters · filed 2017-01-13 | $77.00 derived: sum of 4 quarters · filed 2017-01-13 | ||
| 2015-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | $0.00 derived: sum of 2 quarters · filed 2016-11-29 | $0.00 derived: sum of 3 quarters · filed 2016-11-29 | $31.54K 10-K · filed 2016-11-29 | ||
| 2015-05-31 | $0.00 10-Q · filed 2016-07-13 | $0.00 derived: sum of 2 quarters · filed 2016-07-13 | $31.54K 10-Q · filed 2016-07-13 | $35.72K derived: sum of 4 quarters · filed 2016-07-13 | ||
| 2015-02-28 | $0.00 10-Q · filed 2016-04-13 | $31.54K 10-Q · filed 2016-04-13 | $35.72K derived: sum of 3 quarters · filed 2016-04-13 | |||
| 2014-11-30 | $31.54K 10-Q · filed 2016-01-08 | $35.72K derived: sum of 2 quarters · filed 2016-01-08 | ||||
| 2014-08-31 | $4.17K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27 | $165.79K 10-KT · filed 2014-12-09 | $165.79K 10-K · filed 2015-11-27 | |||
| 2014-07-31 | $39.02K 10-Q · filed 2014-11-14 | $147.17K 10-Q · filed 2014-11-14 | ||||
| 2014-05-31 | $53.12K 10-Q · filed 2015-07-14 | $161.62K 10-Q · filed 2015-07-14 | ||||
| 2014-04-30 | $51.06K 10-Q · filed 2014-06-12 | $108.15K 10-Q · filed 2014-06-12 | ||||
| 2014-02-28 | $49.87K 10-Q · filed 2015-04-14 | $108.49K 10-Q · filed 2015-04-14 | ||||
| 2014-01-31 | $57.09K 10-Q · filed 2014-03-12 | |||||
| 2013-11-30 | $58.63K 10-Q · filed 2015-01-14 | |||||
| 2013-10-31 | $267.36K 10-KT · filed 2014-12-09 | $59.03K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $100.72K derived: sum of 2 quarters · filed 2014-11-14 | $150.90K derived: sum of 3 quarters · filed 2014-11-14 | $267.36K 10-K · filed 2014-01-24 | |
| 2013-08-31 | $227.35K 10-KT · filed 2014-12-09 | |||||
| 2013-07-31 | $41.69K 10-Q · filed 2014-11-14 | $91.87K derived: sum of 2 quarters · filed 2014-11-14 | $208.33K 10-Q · filed 2014-11-14 | $274.16K derived: sum of 4 quarters · filed 2014-11-14 | ||
| 2013-04-30 | $50.17K 10-Q · filed 2014-06-12 | $166.63K 10-Q · filed 2014-06-12 | $232.47K derived: sum of 3 quarters · filed 2014-06-12 | $291.28K derived: sum of 4 quarters · filed 2014-06-12 | ||
| 2013-01-31 | $116.46K 10-Q · filed 2014-03-12 | $182.30K derived: sum of 2 quarters · filed 2014-03-12 | $241.10K derived: sum of 3 quarters · filed 2014-03-12 | $301.00K derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2012-10-31 | $65.84K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $124.65K derived: sum of 2 quarters · filed 2014-01-24 | $184.54K derived: sum of 3 quarters · filed 2014-01-24 | $237.64K 10-K · filed 2014-01-24 | ||
| 2012-07-31 | $58.81K 10-Q · filed 2013-09-10 | $118.70K derived: sum of 2 quarters · filed 2013-09-10 | $171.80K 10-Q · filed 2013-09-10 | $223.21K derived: sum of 4 quarters · filed 2013-09-10 | ||
| 2012-04-30 | $59.90K 10-Q · filed 2013-06-12 | $113.00K 10-Q · filed 2013-06-12 | $164.41K derived: sum of 3 quarters · filed 2013-06-12 | $221.96K derived: sum of 4 quarters · filed 2013-06-12 | ||
| 2012-01-31 | $53.10K 10-Q · filed 2013-03-13 | $104.51K derived: sum of 2 quarters · filed 2013-03-13 | $162.06K derived: sum of 3 quarters · filed 2013-03-13 | $219.91K derived: sum of 4 quarters · filed 2013-03-13 | ||
| 2011-10-31 | $51.41K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $108.97K derived: sum of 2 quarters · filed 2013-01-29 | $166.81K derived: sum of 3 quarters · filed 2013-01-29 | $223.67K 10-K · filed 2013-01-29 | ||
| 2011-07-31 | $57.55K 10-Q · filed 2012-09-12 | $115.40K derived: sum of 2 quarters · filed 2012-09-12 | $172.26K 10-Q · filed 2012-09-12 | $215.76K derived: sum of 4 quarters · filed 2012-09-12 | ||
| 2011-04-30 | $57.84K 10-Q · filed 2012-06-07 | $114.71K 10-Q · filed 2012-06-07 | $158.20K derived: sum of 3 quarters · filed 2012-06-07 | $201.43K derived: sum of 4 quarters · filed 2012-06-07 | ||
| 2011-01-31 | $56.86K 10-Q · filed 2012-03-13 | $100.36K derived: sum of 2 quarters · filed 2012-03-13 | $143.59K derived: sum of 3 quarters · filed 2012-03-13 | |||
| 2010-10-31 | $43.49K derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | $86.73K derived: sum of 2 quarters · filed 2012-01-30 | $167.32K 10-K · filed 2012-01-30 | |||
| 2010-07-31 | $43.23K 10-Q · filed 2011-09-14 | $123.83K 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |